Aegerion Pharmaceuticals, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Net product sales
Cost of product sales
Operating Expenses:
Selling, general and administrative
Research and development
General and administrative
Restructuring costs
Total operating expenses

Loss from operations
Interest expense, net
Interest income
Other income (expense), net
Loss before provision for income taxes
Provision for income taxes
Net loss
Net loss per common share - basic and diluted
Weighted-average shares outstanding - basic and diluted
Weighted-average common shares outstanding - basic and diluted

Comments